Fludarabine phosphate in lymphoma: an important new therapeutic agent

Cancer Treat Res. 1996:85:3-14. doi: 10.1007/978-1-4615-4129-5_1.
No abstract available

Publication types

  • Review

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Hodgkin Disease / drug therapy
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Lymphoma / drug therapy*
  • Multiple Myeloma / drug therapy
  • Vidarabine Phosphate / analogs & derivatives*
  • Vidarabine Phosphate / therapeutic use
  • Waldenstrom Macroglobulinemia / drug therapy

Substances

  • Antimetabolites, Antineoplastic
  • Vidarabine Phosphate
  • fludarabine phosphate